Toward precision medicine in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease. [PDF]
Sim S, Shin YS, Park JW, Park HS.
europepmc +1 more source
Functional toll-like receptor 4 links endotoxin sensing to platelet priming in feline platelets. [PDF]
Li RHL +5 more
europepmc +1 more source
12(S)-HETE regulates the expression of IL-6 and IL-10 in cardiomyocytes through two distinct receptors, TXA2R and BLT2. [PDF]
Mori S +11 more
europepmc +1 more source
Related searches:
Thromboxane, Prostaglandin and Leukotriene Receptors
Annual Review of Pharmacology and Toxicology, 1989Thromboxanes (TX), prostaglandins (PG), and leukotrienes (LT) (eicosa noids) are metabolites of the the 20-carbon fatty acid arachidonic acid. Current evidence supports potential pathophysiologic roles for these autocoids in many diseases (1-3).
P V, Halushka +3 more
openaire +3 more sources
Aspects of the thromboxane receptor system
General Pharmacology: The Vascular System, 19951. The aim of this review is to establish what is known about the thromboxane (TP) receptor, and to identify where future research is headed. In addition, the impact of the recent advances at the molecular level on resolving pharmacological controversies, such as possible subtypes of the TP receptor, is discussed and what molecular information is known
R A, Armstrong, N H, Wilson
openaire +2 more sources
Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade
Vascular Pharmacology, 2004Because sulfonylureas, such as glibenclamide, are used to treat Type 2 diabetes and because this disease is associated with various cardiovascular complications that may be mediated by thromboxane (TX), this study was designed to characterize the role of glibenclamide on TX-mediated contractions in isolated ring segments of bovine coronary arteries and
Sandra L, Pfister +3 more
openaire +2 more sources
Thromboxane synthase inhibitors and receptor antagonists
Cardiovascular Drugs and Therapy, 1992Platelet activation plays a major role in myocardial infarction and in reocclusion following successful thrombolysis, as corroborated by several clinical studies using aspirin. However, the overall reduction of new vascular complications in patients with symptomatic arterial disease by aspirin was only around 25%.
J, Vermylen, H, Deckmyn
openaire +2 more sources
Cellular Activation of Thromboxane Receptorsa
Annals of the New York Academy of Sciences, 1994Thromboxane A2 is an abundant and potent product of arachidonic acid metabolism in human platelets. Its clinical importance is highlighted by the efficacy of aspirin, which, due to its irreversible inhibition of the enzyme PGG/H synthase, selects the anucleate platelet as a particular target for extended duration of action.
B T, Kinsella +4 more
openaire +2 more sources
Thromboxane receptors in human kidney tissues
Prostaglandins & Other Lipid Mediators, 1999Thromboxane (TX) A2 effects in the kidneys include contraction of glomerular mesangial cells and intrarenal vascular tissue. A kidney cDNA encoding a TX receptor expressed in rat renal glomeruli and rat renal arterial smooth muscle cells has been reported. However, TXA2 receptors in human kidneys have not been documented.
G P, Brown, R C, Venuto
openaire +2 more sources
Immunohistochemical localization of thromboxane receptor and thromboxane synthase in rat testis
Endocrinology, 1995The cellular localization of thromboxane A2 receptor (TXR) and thromboxane synthase (TXS) in rat testes was examined with an antibody against the carboxyl-terminal tail of rat TXR and anti-porcine lung TXS antibody. By light microscopy immunoreactivity for TXR was shown to be present in spermatids, whereas spermatogonia, spermatocytes, and spermatozoa ...
N, Takahashi +5 more
openaire +3 more sources

